Results 111 to 120 of about 10,600 (216)

Pan-viral serology implicates enteroviruses in acute flaccid myelitis. [PDF]

, 2019
Since 2012, the United States of America has experienced a biennial spike in pediatric acute flaccid myelitis (AFM)1-6. Epidemiologic evidence suggests non-polio enteroviruses (EVs) are a potential etiology, yet EV RNA is rarely detected in cerebrospinal
Banerji, Debarko, Benson, Leslie, Bove, Riley, Briggs, Benjamin, Cheung, Carly K, Chitnis, Tanuja, Chiu, Charles Y, Chu, Victoria, Crawford, Emily D, DeRisi, Joseph L, Ding, Joy Z, Dominguez, Samuel R, Gelfand, Amy A, Glaser, Carol A, Gorman, Mark P, Hauser, Stephen L, Hawes, Isobel A, Johnson-Kerner, Bethany L, Khan, Lillian M, Konopka-Anstadt, Jennifer L, Krishnamoorthy, Kalpathy S, Lopez, Adriana S, Lyden, Amy, Marine, Rachel L, McMillan, Hugh J, Messacar, Kevin, Nash, Kendall, Ng, Terry Fei Fan, Nix, W Allan, O'Donovan, Brian D, Oberste, M Steven, Pak, John E, Ramachandran, Prashanth S, Ramesh, Akshaya, Sample, Hannah A, Schubert, Ryan D, Sit, Rene, Soldatos, Ariane, Sowa, Gavin M, Tan, Michelle, Tato, Cristina M, Wadford, Debra A, Wilson, Michael R, Wu, Wesley, Yen, Cynthia, Zorn, Kelsey C   +45 more
core  

Het Rijksvaccinatieprogramma in Nederland. Ontwikkelingen in 2006 [PDF]

, 2007
In 2006 several changes were made in the Dutch National Immunisation Programme (NIP): Hepatitis B vaccination at birth was added for children born to mothers positive for hepatitis B surface antigen; a new vaccine for diphtheria, tetanus, pertussis (a ...
Abbink F, Avoort HGAM van der, Berbers WAM, Binnendijk RS van, Boot HJ, Duynhoven YTHP van, Geraedts JLE, Gerritsen AAM, Greeff SC de, Hahne SJM, Hofhuis A, Kemmeren JM, Kimman TG, Klein MR, Koedijk FDH, Koopmans MPG, Kremer K, Maas NAT van der, Mangen MJJ, Meijer A, Mooi FR, Mylius SD, Notermans DW, Op de Coul ELM, Sande MAB van der, Schouls LM, Soolingen D van, Steenbergen JE van, Vermeer-de Bondt PE, Wallinga J, Wit GA de   +30 more
core  

Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies

Pathogens
Introduction: Herpes zoster is caused by the reactivation of latent varicella infection within the sensory ganglia, caused by the varicella-zoster virus (VZV).
Delwyn Zhi Jie Lim, Hong Liang Tey, Brenda Mae Alferez Salada, Jolene Ee Ling Oon, Ee-Jin Darren Seah, Nisha Suyien Chandran, Jiun Yit Pan   +6 more
doaj   +1 more source

Prevention of Herpes Zoster in Chronic Kidney Disease

Giornale di Clinica Nefrologia e Dialisi
The varicella-zoster virus (VZV) is responsible for both primary varicella infection and Herpes Zoster (HZ), the latter resulting from viral reactivation in immunocompromised or elderly individuals.
Barbara Maresca, Giulia Conforti, Silvana Chicca, Marco Galliani   +3 more
doaj   +1 more source

The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts’ Network Scientific Workshop

Vaccines
The burden of herpes zoster (HZ) is recognized worldwide; however, there is seemingly limited information on incidence and vaccination practices in Southeast Asia (SEA).
Gyneth Lourdes G. Bibera, Peter San Martin, Desiree A. M. van Oorschot, Afif Nurul Hidayati, Deliana Permatasari, Sasheela Sri La Sri Ponnampalavanar, Kughan Govinden, Maria Christina Filomena Batac, Joselito Javier, Terapong Tantawichien, Phatu Boonmahittisut, Trinh Minh Trang, Thanh Tuyen Dang Thi   +12 more
doaj   +1 more source

Antiviral treatment for chronic hepatitis B [PDF]

, 1997
An updated review of the antiviral agents currently available or under trial for the treatment of chronic hepatitis B is presented. There are two broad groups: (1) immunomodulators including interferon α (which also has a direct antiviral effect ...
Lai, CL, Wu, PC
core  

A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile

Infection and Drug Resistance, 2018
Federica Brosio,1 Giulia Masetti,1 Giulio Matteo,1 Armando Stefanati,2 Giovanni Gabutti2 1Postgraduate School of Hygiene and Preventive Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy; 2Department of Medical Sciences ...
Brosio F, Masetti G, Matteo G, Stefanati A, Gabutti G   +4 more
doaj  

Cost-effectiveness analysis of herpes zoster vaccination for adults aged 50 years in Zhejiang province, China

Frontiers in Public Health
ObjectiveLive-attenuated zoster vaccine (LZV) and adjuvanted recombinant zoster vaccine (RZV) have been approved for use in China. This study aimed to evaluate and compare the cost-effectiveness of these two herpes zoster (HZ) vaccination strategies in a
Fuxing Chen, Linglin Ding, Yu Hu
doaj   +1 more source

Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial

Human Vaccines & Immunotherapeutics
Phase III multi-country studies (ZOE-50/70) demonstrated that the adjuvanted recombinant zoster vaccine (RZV) was well tolerated and prevented herpes zoster (HZ) in healthy ≥ 50-year-olds, with a vaccine efficacy (VE) > 90% across age groups.
Diana Alexandra Echeverria Proano, Fengcai Zhu, Xiaodong Sun, Jesús Zoco, Jyoti Soni, Neeraj Parmar, S. Omar Ali   +6 more
doaj   +1 more source

Tests on medical microbiology [PDF]

, 2013
МИКРОБИОЛОГИЯ ...
Generalov, I. I., Zheleznyak, N. V.
core